Ascendancy Advisors Releases CCIB Issue 6 on China's Two-Track Capital Strategy

LONDON - EntSun -- Ascendancy Advisors Limited has released Issue 6 of the China Commercial Intelligence Brief, titled "The Two-Track Capital Strategy: Decree 837, the Foreign Investment Action Plan, and the New Logic of China's Capital Account."

The issue examines China's simultaneous tightening of outbound investment controls and renewed efforts to attract foreign capital. It focuses on State Council Decree No. 837, effective 1 July 2026, and Beijing's June 15-measure Foreign Investment Action Plan.

The report argues that these measures are not contradictory. They reflect a new two-track capital strategy: China is opening selected inbound channels for foreign capital, expertise and market participation, while asserting stronger control over outbound investment, technology, services, data and offshore asset transfers.

More on EntSun News

• Official Teaser Trailer Released for Plucked
• Postmortem Pathology Expands Access to Private Autopsy Services in Las Vegas
• Closing Madison's Summer Classic Season With Fantastical Folklore and August Lovers
• How Sacramento Families Are Using Private Autopsies to Protect Inheritances, Resolve Insurance Claims, and Find Closure
• Los Angeles' Best Food: Food Journal Magazine Examines the Trends Shaping the City's Dining Scene

Issue 6 is written for investors, lenders, dealmakers, compliance teams and companies with exposure to Chinese counterparties or China-origin offshore structures. It covers Article 15 security-review risk, offshore restructuring exposure, PRC-side compliance as deal risk, and practical due diligence questions for transaction teams.

The full issue is available here:
https://ascendancyadvisors.substack.com/p/ccib-the-two-track-capital-strategy

Subscription information:
https://theaalgroup.com/subscription/

About Ascendancy Advisors Limited

Ascendancy Advisors Limited is a London-based independent advisory firm providing structured finance advisory, counterparty due diligence and commercial intelligence for complex cross-border mandates.